To test whether the increase in the sub-G1 population could be a consequence of an increase in the apoptotic events due to defects produced during the S phase or the arrest in G2/M upon eribulin treatment, we decided to measure apoptotic cells directly by flow cytometry with annexin V in both sarcoma cell lines. This evidence concerns the gene ANXA5 and sarcoma.